3rd generation glp 1 agonist 🚨 HOT OFF THE PRESS: Retatrutide Phase 3 data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average GLP-1 Receptor Agonists | New

Yes, they reduce liver fat and inflammation

Unlike the simple sugars glucose and fructose, allulose is not metabolized by the body, and doesn't contribute to elevated postprandial blood glucose levels

Also, due to the important role of endothelial dysfunction in CVD, the effects of GLP-1RA on flow-mediated vasodilation (FMD) in patients remain to be investigated for their contribution to the CVD actions of GLP-1RAs

You may benefit from a longer initial treatment course, a more gradual taper, or a commitment to maintenance dosing rather than complete discontinuation

Meta-analysis on the association between DPP-4 inhibitors and bone mineral density and osteoporosis

As relatively new classes of diabetes medications, GLP-1RA and SGLT2 agents are available as branded products with no generic equivalents